Lion Street Advisors, LLC Cardiol Therapeutics Inc. Transaction History
Lion Street Advisors, LLC
- $307 Million
- Q4 2024
A detailed history of Lion Street Advisors, LLC transactions in Cardiol Therapeutics Inc. stock. As of the latest transaction made, Lion Street Advisors, LLC holds 307,666 shares of CRDL stock, worth $359,969. This represents 0.13% of its overall portfolio holdings.
Number of Shares
307,666
Previous 273,281
12.58%
Holding current value
$359,969
Previous $541,000
26.8%
% of portfolio
0.13%
Previous 0.19%
Shares
4 transactions
Others Institutions Holding CRDL
# of Institutions
46Shares Held
7.58MCall Options Held
4.9KPut Options Held
3.8K-
Tejara Capital LTD London, X03.12MShares$3.65 Million2.61% of portfolio
-
Advisor Shares Investments LLC Bethesda, MD882KShares$1.03 Million0.23% of portfolio
-
Mmcap International Inc. Spc Grand Cayman, E9796KShares$930,8810.31% of portfolio
-
Pvg Asset Management Corp Golden, CO487KShares$570,1353.54% of portfolio
-
Cambridge Investment Research Advisors, Inc.331KShares$386,6900.0% of portfolio
About Cardiol Therapeutics Inc.
- Ticker CRDL
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 61,942,500
- Market Cap $72.5M
- Description
- Cardiol Therapeutics Inc., a clinical-stage life sciences company, focuses on the research and development of anti-fibrotic and anti-inflammatory therapies for the treatment of cardiovascular disease (CVD). Its lead product is CardiolRx, which is in Phase II/III multi-national, randomized, double-blind, and placebo-controlled study to evaluate t...